Search for Clinical Trial Results
Papillary Renal Cell Carcinoma - 26 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Savolitinib vs. Sunitinib in MET-driven PRCC Condition:
Interventions: |
Recruiting |
Study Name: Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer Condition:
|
Completed |
Study Name: Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer Condition: Intraabdominal Cancers (Various Types) Date: 2006-01-26 Interventions: Biological: Cancer Macrobead placement in abdominal cavity 8 macrobeads per kg |
Recruiting |
Study Name: Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colorectal Cancer Condition: Colorectal Cancers Date: 2014-01-21 Interventions: Biological: RENCA macrobeads Other Names:
|
Recruiting |
Study Name: Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic or Colorectal Cancer Condition:
Date: 2010-01-20 Interventions: Biological: Cancer macrobead placement in abdominal cavity 8 macrobeads per kilogram |
Completed |
Study Name: TroVax Renal Immunotherapy Survival Trial Condition: Clear Cell Renal Carcinoma Date: 2006-11-08 Interventions: Biological: Trovax 1ml IM injection 2-8 weeks apart. |
Terminated |
Study Name: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer Condition:
|
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition:
|
Active, not recruiting |
Study Name: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant Condition:
|